| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | Taiwan | 2 | |
| #3 | United States | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | EPO (European Patent Office) | 1 | |
| #9 | Israel | 1 | |
| #10 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lannutti Brian | 12 |
| #2 | Jessen Katti | 12 |
| #3 | Watkins Jeffry Dean | 9 |
| #4 | Vo Thanh-Trang | 9 |
| #5 | Miller Langdon | 2 |
| #6 | Brian Lannutti | 1 |
| #7 | Vo Thanh Trang | 1 |
| #8 | Watkins J Monty | 1 |
| #9 | Thanh-Trang Vo | 1 |
| #10 | Ko Mira | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020237173A1 | Anti-ror1/anti-cd3 bispecific binding molecules | |
| WO2020160527A1 | Cancer treatment with ror1 antibody immunoconjugates | |
| KR20200062161A | ROR1 antibody immunoconjugate |